Target intelligence / Profile preview

Hemagglutinin protein, H1 subtype (H1)

Target
H1
Molecular classification
Glycoprotein, Viral envelope protein, Receptor-binding protein
01

Overview

The Hemagglutinin protein, H1 subtype (H1) is a trimeric glycoprotein on the surface of influenza A viruses, forming elongated spikes that project from the viral envelope. It consists of HA1 and HA2 subunits linked by disulfide bonds after proteolytic cleavage of the HA0 precursor, with a membrane-distal globular head domain primarily from HA1 responsible for binding sialic acid receptors on host cells, and a membrane-proximal stem domain involving both HA1 and HA2 that mediates low-pH-induced membrane fusion during viral entry. The receptor-binding subdomain in the head recognizes sialylated glycans, enabling viral attachment, while the fusion peptide at the N-terminus of HA2 drives endosomal-viral membrane fusion after conformational changes triggered by acidic conditions. H1 belongs to group 1 hemagglutinins, characterized by specific structural features like the interhelical loop in the fusion subdomain influencing subdomain orientations. In disease, H1 is central to influenza infections, including pandemics like 1918 and 2009, as the primary antigen eliciting neutralizing antibodies and driving viral evolution through antigenic drift and shift. Antigenic sites surround the receptor-binding pocket, with glycosylation modulating immune evasion. While not a direct small-molecule drug target, H1 is key for vaccine design, with monoclonal antibodies targeting conserved stem epitopes showing broad potential against diverse strains.

Other names
HAH1 hemagglutininInfluenza A virus hemagglutinin H1
02

Biological functions

Receptor bindingMembrane fusionViral attachmentViral entry
03

Disease associations

Infection

Beyond the preview

Go deeper on Hemagglutinin protein, H1 subtype (H1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hemagglutinin protein, H1 subtype (H1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call